{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:40:29Z","timestamp":1772912429529,"version":"3.50.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01023","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T14:34:55Z","timestamp":1568298895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunological Efficacy of Tenofovir Disproxil Fumarate-Containing Regimens in Patients With HIV-HBV Coinfection: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Taiyi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"B1","unstructured":"Panel on antiretroviral guidelines for adults and adolescentsGuidelines for the use of antiretroviral agents in adults and adolescents living with HIV"},{"key":"B2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3851\/IMP1645","article-title":"Efficacy of tenofovir disoproxil fumarate\/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand","volume":"15","author":"Avihingsanon","year":"2010","journal-title":"Antiviral Therapy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12876-015-0308-0","article-title":"HBV genotypes and response to tenofovir disoproxil fumarate in HIV\/HBV-coinfected persons","volume":"15","author":"Bihl","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1097\/QAD.0000000000000795","article-title":"Rates and determinants of hepatitis B \u2018e\u2019 antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus","volume":"29","author":"Boyd","year":"2015","journal-title":"AIDS"},{"key":"B5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jgh.13156","article-title":"Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa","volume":"31","author":"Boyd","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/liv.13641","article-title":"Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B","volume":"38","author":"Buti","year":"2018","journal-title":"Liver Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/QAD.0b013e32836011c2","article-title":"Tenofovir-based combination therapy for HIV\/HBV co-infection: factors associated with a partial HBV virological response in patients with undetectable HIV viraemia","volume":"27","author":"Childs","year":"2013","journal-title":"AIDS"},{"key":"B8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jcv.2013.02.004","article-title":"Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)\/human immunodeficiency virus type 1 (HIV-1) co-infected patients","volume":"57","author":"Coffin","year":"2013","journal-title":"J. Clin. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1053\/j.gastro.2010.08.045","article-title":"Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus","volume":"139","author":"De Vries-Sluijs","year":"2010","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1086\/380398","article-title":"Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus","volume":"189","author":"Dore","year":"2004","journal-title":"J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/gut.2004.060327","article-title":"Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D","volume":"54","author":"Erhardt","year":"2005","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1572-0241.2006.00418.x","article-title":"Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype","volume":"101","author":"Flink","year":"2006","journal-title":"Am J. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00198-018-4379-y","article-title":"Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation","volume":"29","author":"Goh","year":"2018","journal-title":"Osteoporos. Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/QAI.0b013e3182a60f7d","article-title":"HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes","volume":"64","author":"Hamers","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.tube.2012.03.008","article-title":"A novel assay detecting recall response to Mycobacterium tuberculosis: comparison with existing assays","volume":"92","author":"Hsu","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"B17","unstructured":""},{"key":"B18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/2325957415586258","article-title":"Outcomes in HIV\/HBV-coinfected patients in the tenofovir era are greatly affected by immune suppression","volume":"14","author":"Huang","year":"2015","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043143","article-title":"Hepatitis B surface antigen concentrations in patients with HIV\/HBV co-infection","volume":"7","author":"Jaroszewicz","year":"2012","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/hep.26686","article-title":"No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B","volume":"59","author":"Kitrinos","year":"2014","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1365-2893.2012.01601.x","article-title":"Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients","volume":"19","author":"Kosi","year":"2012","journal-title":"J. Viral. Hepat."},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAI.0000000000000927","article-title":"Lamivudine monotherapy-based cART is efficacious for HBV treatment in HIV\/HBV coinfection when baseline HBV DNA <20,000 IU\/mL","volume":"72","author":"Li","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jhep.2016.02.009","article-title":"Attacking hepatitis B virus cccDNA\u2014the holy grail to hepatitis B cure","volume":"64","author":"Lucifora","year":"2016","journal-title":"J. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12985-018-1050-3","article-title":"Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV\/HIV coinfection: a meta-analysis","volume":"15","author":"Luo","year":"2018","journal-title":"Virol. J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QAD.0b013e328340fde2","article-title":"Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues","volume":"25","author":"Martin-Carbonero","year":"2011","journal-title":"AIDS"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061297","article-title":"Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals","volume":"8","author":"Matthews","year":"2013","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/hep.22462","article-title":"A randomized trial of combination hepatitis B therapy in HIV\/HBV coinfected antiretroviral naive individuals in Thailand","volume":"48","author":"Matthews","year":"2008","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/QAD.0b013e328352224d","article-title":"Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients","volume":"26","author":"Maylin","year":"2012","journal-title":"AIDS"},{"key":"B29","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/520752","article-title":"Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion","volume":"45","author":"Miailhes","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0004-9514(14)60281-6","article-title":"Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro)","volume":"48","author":"Moseley","year":"2002","journal-title":"Aust. J. Physiother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/QAD.0b013e3282f303bf","article-title":"Interruptions of tenofovir\/emtricitabine-based antiretroviral therapy in patients with HIV\/hepatitis B virus co-infection","volume":"22","author":"Nuesch","year":"2008","journal-title":"AIDS"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1097\/00002030-200211220-00023","article-title":"Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine","volume":"16","author":"Nunez","year":"2002","journal-title":"AIDS"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/hep.21388","article-title":"Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127","volume":"44","author":"Peters","year":"2006","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068152","article-title":"Suppression of HBV by tenofovir in HBV\/HIV coinfected patients: a systematic review and meta-analysis","volume":"8","author":"Price","year":"2013","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/QAD.0000000000001454","article-title":"Hepatitis B serological markers and plasma DNA concentrations","volume":"31","author":"Price","year":"2017","journal-title":"AIDS"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1086\/345770","article-title":"Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus\/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed","volume":"186","author":"Ristig","year":"2002","journal-title":"J. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1037\/0033-2909.86.3.638","article-title":"The file drawer problem and tolerance for null results","volume":"86","author":"Rosenthal","year":"1979","journal-title":"Psychological Bulletin"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/jac\/dki396","article-title":"Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus","volume":"56","author":"Stephan","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/bmj.316.7129.469","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"316","author":"Stuck","year":"1998","journal-title":"BMJ"},{"key":"B43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2893.2009.01084.x","article-title":"Reduced glomerular filtration rate but sustained virologic response in HIV\/hepatitis B co-infected individuals on long-term tenofovir","volume":"16","author":"Tan","year":"2009","journal-title":"J. Viral. Hepat."},{"key":"B44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1089\/aid.2007.9999","article-title":"Treatment of HIV\/HBV coinfection: clinical and virologic issues","volume":"9","author":"Thio","year":"2007","journal-title":"AIDS Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"},{"key":"B46","article-title":"Global HIV & AIDS statistics\u20142018 fact sheet. WORLD AIDS DAY","year":"2018"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088552","article-title":"Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia","volume":"9","author":"Van Griensven","year":"2014","journal-title":"PLoS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/cid\/cix122","article-title":"Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia","volume":"64","author":"Vinikoor","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4103\/0366-6999.174509","article-title":"Efficacy and safety of tenofovir and lamivudine in combination with efavirenz in patients co-infected with human immunodeficiency virus and hepatitis B virus in China","volume":"129","author":"Wu","year":"2016","journal-title":"Chin. Med. J. (Engl)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ijc.30086","article-title":"Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women","volume":"139","author":"Yang","year":"2016","journal-title":"Int J Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","article-title":"Towards an HBV cure: state-of-the-art and unresolved questions\u2014report of the ANRS workshop on HBV cure","volume":"64","author":"Zeisel","year":"2015","journal-title":"Gut"},{"key":"B52","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/infdis\/jis439","article-title":"Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV","volume":"206","author":"Zoutendijk","year":"2012","journal-title":"J. Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01023\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T14:35:02Z","timestamp":1568298902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01023\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":52,"alternative-id":["10.3389\/fphar.2019.01023"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01023","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"article-number":"1023"}}